Nanoparticles of increasingly smaller particle size and various material compositions are being developed for the pharmaceutical, biomedical, electronics, optoelectronics, energy, catalyst and ...
The author examines the process of method development, with reference to ISO 13320:2009 and relevant monographs from the United States and European pharmacopoeias. Particle size is a critical quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback